AU2001270851A1 - Peptides and their use in assays for cardiovascular disease - Google Patents

Peptides and their use in assays for cardiovascular disease

Info

Publication number
AU2001270851A1
AU2001270851A1 AU2001270851A AU7085101A AU2001270851A1 AU 2001270851 A1 AU2001270851 A1 AU 2001270851A1 AU 2001270851 A AU2001270851 A AU 2001270851A AU 7085101 A AU7085101 A AU 7085101A AU 2001270851 A1 AU2001270851 A1 AU 2001270851A1
Authority
AU
Australia
Prior art keywords
assays
peptides
cardiovascular disease
cyclised
affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270851A
Inventor
Outi Narvanen
Seppo Yla-Herttuala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ark Therapeutics Ltd
Original Assignee
Ark Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Ltd filed Critical Ark Therapeutics Ltd
Publication of AU2001270851A1 publication Critical patent/AU2001270851A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Abstract

A peptide having affinity for oxidised low density lipoprotein, in cyclised or multimeric form is useful in an enzyme immunosolvent assay, to detect oxLDL which is a marker of coronary heart disease.
AU2001270851A 2000-07-18 2001-07-18 Peptides and their use in assays for cardiovascular disease Abandoned AU2001270851A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0017641 2000-07-18
GBGB0017641.2A GB0017641D0 (en) 2000-07-18 2000-07-18 Peptides and their use
PCT/GB2001/003212 WO2002006314A2 (en) 2000-07-18 2001-07-18 Peptides and their use in assays for cardiovascular disease

Publications (1)

Publication Number Publication Date
AU2001270851A1 true AU2001270851A1 (en) 2002-01-30

Family

ID=9895897

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270851A Abandoned AU2001270851A1 (en) 2000-07-18 2001-07-18 Peptides and their use in assays for cardiovascular disease

Country Status (12)

Country Link
US (2) US20040091934A1 (en)
EP (1) EP1301537B1 (en)
JP (1) JP2004504327A (en)
AT (1) ATE408626T1 (en)
AU (1) AU2001270851A1 (en)
CA (1) CA2417789A1 (en)
DE (1) DE60135846D1 (en)
DK (1) DK1301537T3 (en)
ES (1) ES2312455T3 (en)
GB (1) GB0017641D0 (en)
PT (1) PT1301537E (en)
WO (1) WO2002006314A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0103754L (en) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptides from apolipoprotein B, use thereof immunization, method of diagnosis or therapeutic treatment of ischemic cardiovascular diseases, and pharmaceutical composition and vaccine containing such peptide
EP1438060B1 (en) 2001-09-28 2015-11-11 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug
EP1732383A4 (en) 2004-04-06 2007-05-02 Cedars Sinai Medical Center Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
MX2009004460A (en) * 2006-10-26 2009-07-09 Abbott Lab Immunoassay of analytes in samples containing endogenous anti-analyte antibodies.
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
JP2010515023A (en) * 2006-12-22 2010-05-06 アボット・ラボラトリーズ Cardiovascular autoimmune disease panel and method of use thereof
RU2013126626A (en) 2010-11-12 2014-12-20 Седарс-Синаи Медикал Сентер IMMUNOMODULATING METHODS AND SYSTEMS FOR TREATMENT AND / OR PREVENTION OF HYPERTENSIONS
RU2013126628A (en) 2010-11-12 2014-12-20 Седарс-Синаи Медикал Сентер IMMUNOMODULATING METHODS AND SYSTEMS FOR TREATING AND / OR PREVENTING ANEURISM
JP5857312B2 (en) * 2011-08-11 2016-02-10 積水メディカル株式会社 Diagnostic marker for heart disease
CN107085025B (en) * 2016-02-15 2019-09-17 太原师范学院 A kind of self assembly trilamellar membrane electrode and its preparation method and application
WO2017210360A1 (en) 2016-05-31 2017-12-07 Cardiovax, Llc Methods for diagnosing and treating systemic lupus erythematosus
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN111855986A (en) * 2019-04-25 2020-10-30 常州博闻迪医药股份有限公司 Kit for joint quantitative detection of five cardiac markers and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
AU3442397A (en) * 1997-06-20 1999-01-04 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins

Also Published As

Publication number Publication date
WO2002006314A2 (en) 2002-01-24
ATE408626T1 (en) 2008-10-15
CA2417789A1 (en) 2002-01-24
PT1301537E (en) 2008-12-04
EP1301537A2 (en) 2003-04-16
US20080261234A1 (en) 2008-10-23
JP2004504327A (en) 2004-02-12
WO2002006314A3 (en) 2002-04-18
US20040091934A1 (en) 2004-05-13
EP1301537B1 (en) 2008-09-17
ES2312455T3 (en) 2009-03-01
GB0017641D0 (en) 2000-09-06
DK1301537T3 (en) 2008-12-08
DE60135846D1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
AU2001270851A1 (en) Peptides and their use in assays for cardiovascular disease
GB9812523D0 (en) Peptide inhibitors of hepatitis c virus ns3 protease
WO2001049097A3 (en) Alzheimer's disease secretase, app substrates therefor, and uses therefor
DE60144145D1 (en) Subtilisin variant
EP2518155A3 (en) Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
HUP0103601A2 (en) Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
WO2002006457A3 (en) Novel lipase genes
KR880701728A (en) Methods for diagnostic assay of tissue-type and urokinase-type plasminogen activator inhibitors and coding genes for inhibitors
WO2005042771A3 (en) Colorimetric substrates, colorimetric sensors, and methods of use
WO2001075157A1 (en) Probe for constructing probe polymer, method of constructing probe polymer and utilization thereof
Oyama et al. Purification and characterization of a thrombin like enzyme, elegaxobin II, with lys-bradykinin releasing activity from the venom of Trimeresurus elegans (Sakishima-Habu)
Tsushima et al. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A
WO2002020568A3 (en) Mutant peptides derived from bad and their use to identify substances which bind to a member of the bcl-2 family of proteins
DE60027030D1 (en) MEMBRANE TRANSLLATING PEPTIDE AS AN ACTIVE TRANSPORT SYSTEM
WO2001094627A3 (en) Assay techniques based on growth stage dependent expression in c. elegans
EP1612266A3 (en) Prostaglandin reductase
BR9811412A (en) Subtilase enzyme variant having improved detergent washing performance, isolated DNA sequence, expression vector, microbial host cell, processes for producing a variant and for identifying a protease variant, composition, and, use of a subtilase variant
WO2003002730A3 (en) Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method
Nasuno Differentiation of Aspergillus sojae from Aspergillus oryzae by polyacrylamide gel disc electrophoresis
WO2002102847A1 (en) Novel ligand and dna thereof
AU4908799A (en) Determination of the hydrophobic pulmonary surfactant protein sp-c
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
ATE310823T1 (en) EXPRESSION SYSTEM FOR THE PRODUCTION OF PROTEINS IN MUSHROOMS
ATE510922T1 (en) INDUCABLE PROMOTORS
ATE389029T1 (en) PROTEASE ASSAY TO CONTROL DRUG THERAPY